You have no items in your shopping cart.
Cart summary
Item 1 of 4
Item 1 of 4
DLL4 Antibody
Catalog Number: orb1806225
| Catalog Number | orb1806225 |
|---|---|
| Category | Antibodies |
| Description | Anti-DLL4 Reference Antibody is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa. |
| Target | DLL4 |
| Clonality | Monoclonal |
| Conjugation | Unconjugated |
| Reactivity | Human |
| Concentration | 1 mg/mL |
| Buffer/Preservatives | 100 mM Proline/Acetic acid 20mM Arginine pH 5.0 |
| Purity | > 95% |
| Purification | Protein A |
| UniProt ID | Q9NR61 |
| MW | 146.17 kDa |
| Tested applications | ELISA, FA, FACS, In vivo |
| Expression System | CHO |
| Endotoxins | < 0.001 EU/ug |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
| Note | For research use only |
Anti-DLL4 Reference Antibody (navicixizumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
The purity of Anti-DLL4 Reference Antibody (navicixizumab)is more than 95% ;determined by SEC-HPLC.
Immobilized human VEGF165 His at 2 μg/mL can bind Anti-DLL4 Reference Antibody (navicixizumab);EC50=0.01191μg/mL.
- Item 1 of 4
- Item 1 of 4
- Item 1 of 2
- Item 1 of 2
- Item 1 of 2
